The novel B-cell epitope peptide vaccine, MAX449, exhibits significant anti-tumor efficacy and enhances the therapeutic effects of PD-1 antibodies on tumors by modulating the activity of PMN-MDSCs.
新型 B 细胞表位肽疫苗 MAX449 表现出显著的抗肿瘤功效，并通过调节 PMN-MDSC 的活性来增强 PD-1 抗体对肿瘤的治疗效果。
期刊:Theranostics
影响因子:13.3
doi:10.7150/thno.122439
Yang Hong, Han Xiao, Deng Boshao, Zhao Yunpei, Zhao Jing, Wu Yufei, Liu Guokang, Zeng Shiyu, Wang Siyi, Shen Zhejuan, Wang Lulu, Sun Zihan, Lu Wenping, Wu Yuzhang, Chen Jian
